Chronic kidney disease and the aging population
Abstract
Youth, which is forgiven everything, forgives itself nothing: age, which forgives itself everything, is forgiven nothing. George Bernard Shaw The proportion of older people in the general population is steadily increasing worldwide, with the most rapid growth in low- and middle-income countries [1]. This demographic change is to be celebrated, because it is the consequence of socioeconomic development and better life expectancy. However, population aging also has important implications for society - in diverse areas including health systems, labor markets, public policy, social programs, and family dynamics [2]. A successful response to the aging population will require capitalizing on the opportunities that this transition offers, as well as effectively addressing its challenges. Chronic kidney disease (CKD) is an important public health problem that is characterized by poor health outcomes and very high health care costs. CKD is a major risk multiplier in patients with diabetes, hypertension, heart disease and stroke - all of which are key causes of death and disability in older people [3]. Since the prevalence of CKD is higher in older people, the health impact of population aging will depend in part on how the kidney community responds. March 13, 2014 will mark the celebration of the 9th World Kidney Day (WKD), an annual event jointly sponsored by the International Society of Nephrology and the International Federation of Kidney Foundations. Since its inception in 2006, WKD has become the most successful effort to raise awareness among policymakers and the general public about the importance of kidney disease. The topic for WKD 2014 is «CKD in older people». This article reviews the key links between kidney function, age, health and illness - and discusses the implications of the aging population for the care of people with CKD.
About the Authors
Tonelli Marcello
University of Alberta, Alberta, Canada
Russian Federation
Russian Federation
Riella Miguel
Catholic University of Parana, Curitiba, Brazil
Russian Federation
Russian Federation
References
1. World Health Organization. Good health adds life to years: Global brief for World Health Day 2012. Geneva, 2012.
2. Wiener J.M., Tilly J. Population ageing in the United States of America: implications for public programmes // Int. J. Epidemiol. 2002. 31. P. 776-781.
3. Couser W.G., Remuzzi G., Mendis S. et al. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases // Kidney Int. 2011. 80. P. 1258-1270.
4. Select Committee on Public Service and Demographic Change. Ready for Aging? Report. House of Lords: London, 2013.
5. Davies D.F., Shock N.W. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males // J. Clin. Invest. 1950. 29. P. 496-507.
6. Zhang L., Wang F., Wang L. et al. Prevalence of chronic kidney disease in China: a cross-sectional survey // Lancet. 2012. 379. P. 815-822.
7. Coresh J., Selvin E., Stevens L.A. et al. Prevalence of chronic kidney disease in the United States // JAMA. 2007. 298. P. 2038-2047.
8. Zhang Q.L., Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review // BMC Public. Health. 2008. 8. P. 117.
9. Arora P., Vasa P., Brenner D. et al. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey // CMAJ. 2013. 185. P. E417-423.
10. James M.T., Hemmelgarn B.R., Tonelli M. Early recognition and prevention of chronic kidney disease // Lancet. 2010. 375. P. 1296-1309.
11. Kurella M., Covinsky K.E., Collins A.J. et al. Octogenarians and nonagenarians starting dialysis in the United States // Ann. Intern. Med. 2007. 146. P. 177-183.
12. Hemmelgarn B.R., James M.T., Manns B.J. et al. Rates of treated and untreated kidney failure in older vs younger adults // JAMA. 2012. 307. P. 2507-2515.
13. Keith D.S., Nichols G.A., Gullion C.M. et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization // Arch. Intern. Med. 2004. 164. P. 659-663.
14. Hemmelgarn B.R., Manns B.J., Lloyd A. et al. Relation between kidney function, proteinuria, and adverse outcomes // JAMA. 2010. 303. P. 423-429.
15. O’Hare A.M., Bertenthal D., Covinsky K.E. et al. Mortality risk stratification in chronic kidney disease: one size for all ages? // J. Am. Soc. Nephrol. 2006. 17. P. 846-853.
16. Stevens P.E., Levin A. Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group M. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline // Ann. Intern. Med. 2013. 158. P. 825-830.
17. Thorsteinsdottir B., Montori V.M., Prokop L.J. et al. Ageism vs. the technical imperative, applying the GRADE framework to the evidence on hemodialysis in very elderly patients // Clin. Interv. Aging. 2013. 8. P. 797-807.
18. Chandna S.M., Da Silva-Gane M., Marshall C. et al. Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy // Nephrol. Dial. Transplant. 2011. 26. P. 1608-1614.
19. Murtagh F.E., Marsh J.E., Donohoe P. et al. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5 // Nephrol. Dial. Transplant. 2007. 22. P. 1955-1962.
20. Kurella Tamura M., Covinsky K.E., Chertow G.M. et al. Functional status of elderly adults before and after initiation of dialysis // N. Engl. J. Med. 2009. 361. P. 1539-1547.
21. Lamping D.L., Constantinovici N., Roderick P. et al. Clinical outcomes, quality of life, and costs in the North Thames Dialysis Study of elderly people on dialysis: a prospective cohort study // Lancet. 2000. 356. P. 1543-1550.
22. Unruh M.L., Newman A.B., Larive B. et al. The influence of age on changes in health-related quality of life over three years in a cohort undergoing hemodialysis // J. Am. Geriatr. Soc. 2008. 56. P. 1608-1617.
23. Knoll G.A. Kidney transplantation in the older adult // Am. J. Kidney Dis. 2013. 61. P. 790-797.
24. Merion R.M., Ashby V.B., Wolfe R.A. et al. Deceased-donor characteristics and the survival benefit of kidney transplantation // JAMA. 2005. 294. P. 2726-2733.
25. Cohen B., Smits J.M., Haase B. et al. Expanding the donor pool to increase renal transplantation // Nephrol. Dial. Transplant. 2005. 20. P. 34-41.
26. Gill J., Bunnapradist S., Danovitch G.M. et al. Outcomes of kidney transplantation from older living donors to older recipients // Am. J. Kidney Dis. 2008. 52. P. 541-552.
27. Gill J.S., Tonelli M., Johnson N. et al. The impact of waiting time and comorbid conditions on the survival benefit of kidney transplantation // Kidney Int. 2005. 68. P. 2345-2351.
28. O’Hare A.M., Kaufman J.S., Covinsky K.E. et al. Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease: is the evidence base relevant to older adults? // Ann. Intern. Med. 2009. 150. P. 717-724.
29. Mohanlal V., Weir M. Kidney Transplantation in the Elderly: It’s Not All Gloom and Doom // ASN Kidney News. 2011. 3. P. 15-17.
Review
For citations:
Marcello T., Miguel R. Chronic kidney disease and the aging population. Nephrology and Dialysis. 2014;16(1):6-10. (In Russ.)
Views:
41
Email this article 